Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis.

Maarten C.C.M. Hulshof, Radboud W. Koot, Eric C. Schimmel, Fido Dekker, D. Andries Bosch, Dionisio González González, Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution. Strahlentherapie Und Onkologie. ,vol. 177, pp. 283- 290 ,(2001) , 10.1007/PL00002409

Kaisorn Chaichana, Scott Parker, Alessandro Olivi, Alfredo Quiñones-Hinojosa, A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. Journal of Neurosurgery. ,vol. 112, pp. 997- 1004 ,(2010) , 10.3171/2009.9.JNS09805

Ashwatha Narayana, Deborah Gruber, Saroj Kunnakkat, John G. Golfinos, Erik Parker, Shahzad Raza, David Zagzag, Patricia Eagan, Michael L. Gruber, A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma. Journal of Neurosurgery. ,vol. 116, pp. 341- 345 ,(2012) , 10.3171/2011.9.JNS11656

Yang Wang, Li Pan, Xiao-fang Sheng, Shu Chen, Jia-zhong Dai, Nimotuzumab, a humanized monoclonal antibody specific for the EGFR, in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma multiforme: First results in Chinese patients. Asia-pacific Journal of Clinical Oncology. ,vol. 12, pp. 23- 29 ,(2016) , 10.1111/AJCO.12166

Kaisorn L. Chaichana, Aditya N. Halthore, Scott L. Parker, Alessandro Olivi, Jon D. Weingart, Henry Brem, Alfredo Quinones-Hinojosa, Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article. Journal of Neurosurgery. ,vol. 114, pp. 604- 612 ,(2011) , 10.3171/2010.4.JNS091340

Robert Owen Dillman, Christopher Michael Duma, Robin Anne Ellis, Andrew Nimitz Cornforth, Patric Michael Schiltz, Shari Lynn Sharp, Madeline Carol DePriest, Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma. Journal of Immunotherapy. ,vol. 32, pp. 914- 919 ,(2009) , 10.1097/CJI.0B013E3181B2910F

Alissa A. Thomas, Cameron W. Brennan, Lisa M. DeAngelis, Antonio M. Omuro, Emerging Therapies for Glioblastoma JAMA Neurology. ,vol. 71, pp. 1437- 1444 ,(2014) , 10.1001/JAMANEUROL.2014.1701

Maria Teresa Solomón, Julio César Selva, Javier Figueredo, José Vaquer, Carolina Toledo, Nelson Quintanal, Silvia Salva, Rafael Domíngez, José Alert, Jorge Juan Marinello, Mauricio Catalá, Martha González Griego, Juan Antonio Martell, Patricia Lorenzo Luaces, Javier Ballesteros, Niurys de-Castro, Ferdinand Bach, Tania Crombet, Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial BMC Cancer. ,vol. 13, pp. 299- 299 ,(2013) , 10.1186/1471-2407-13-299

Kenneth F. Hofland, Steinbjørn Hansen, Morten Sorensen, Silke Engelholm, Henrik P. Schultz, Aida Muhic, Kirsten Grunnet, Anders Ask, Junia C. Costa, Charlotte Kristiansen, Carsten Thomsen, Hans Skovgaard Poulsen, Ulrik Lassen, Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study. Acta Oncologica. ,vol. 53, pp. 939- 944 ,(2014) , 10.3109/0284186X.2013.879607

LESLEY SNELLING, CURTIS T. MIYAMOTO, HANS BENDER, LUTHER W. BRADY, ZENON STEPLEWSKI, REINER CLASS, JACQUELINE EMRICH, MICHAEL A. RACKOVER, Epidermal Growth Factor Receptor 425 Monoclonal Antibodies Radiolabeled with Iodine-125 in the Adjuvant Treatment of High-Grade Astrocytomas Hybridoma. ,vol. 14, pp. 111- 114 ,(1995) , 10.1089/HYB.1995.14.111